AXIM Biotech Clinical Study to Develop Bioequivalent Product to Marinol Listed on Clinicaltrials.gov
May 15, 2017 13:03 pm UTC| Business
NEW YORK, May 15, 2017 -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that information on the company’s Bioavailability Study on...
AXIM Biotech Clinical Study to Develop Bioequivalent Product to Marinol Listed on Clinicaltrials.gov
May 15, 2017 13:03 pm UTC| Business
NEW YORK, May 15, 2017 -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that information on the company’s Bioavailability Study on...
Newtek Small Business Finance, LLC Increases Capital One Revolving Credit Facility to $100.0 Million
May 15, 2017 13:03 pm UTC| Business
LAKE SUCCESS, N.Y., May 15, 2017 -- Newtek Business Services Corp. (“Newtek” or the “Company”), (Nasdaq:NEWT), an internally managed business development company ("BDC"), today announced that Newtek Small Business...
Newtek Small Business Finance, LLC Increases Capital One Revolving Credit Facility to $100.0 Million
May 15, 2017 13:03 pm UTC| Business
LAKE SUCCESS, N.Y., May 15, 2017 -- Newtek Business Services Corp. (“Newtek” or the “Company”), (Nasdaq:NEWT), an internally managed business development company ("BDC"), today announced that Newtek Small Business...
Towerstream Reports Upon First Quarter Results for 2017 and Comments on Key Performance Indicators
May 15, 2017 13:03 pm UTC| Business
MIDDLETOWN, R.I., May 15, 2017 -- Towerstream Corporation (OTCQB:TWER), a Fixed Wireless Fiber Alternative Provider, announced today financial results for the quarter ended March 31, 2017. OVERVIEW "Towerstream has...
AXIM Biotech Clinical Study to Develop Bioequivalent Product to Marinol Listed on Clinicaltrials.gov
May 15, 2017 13:03 pm UTC| Business
NEW YORK, May 15, 2017 -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that information on the company’s Bioavailability Study on...
AXIM Biotech Clinical Study to Develop Bioequivalent Product to Marinol Listed on Clinicaltrials.gov
May 15, 2017 13:03 pm UTC| Business
NEW YORK, May 15, 2017 -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that information on the company’s Bioavailability Study on...
Electricity from farm waste: how biogas could help Malawians with no power
What the Supreme Court is doing right in considering Trump’s immunity case
US election: why it’s not the protesters’ votes that the Democrats should worry about
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects